Sociedad Americana de Hirudoterapia

Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides

Basic science published in Chemotherapy (2006)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Resistencia antimicrobianaFarmacología salivalZavalova LL et al. · Chemotherapy, 2006

Abstract

BACKGROUND: Since bactericidal properties of some lysozymes are independent of their glycosidase activity, we have investigated this phenomenon for destabilase-lysozyme (DL) from medicinal leech (Hirudo medicinalis). METHODS: Glycosidase activity was determined on Micrococcus luteus, non-enzymatic antibacterial activity of heat-treated DL and of synthetic peptides alpha1, alpha2 and alpha3 (fragments of its primary structure) on M. luteus, Escherichia coli, Bacillus brevis and Streptomyces chrysomallus. RESULTS: Glycosidase activity disappeared after the heating of native DL at 100 degrees C for 40 min. Antibacterial activity of heat-treated DL for M. luteus MDMSU128 and MDMSU140 expressed as minimal inhibitory concentration was 9.8.10(-8) and 12.10(-8) M, respectively, and to E. coli MDMSU52 11.10(-8) M. Antibacterial activity of synthetic peptide alpha1 for M. luteus MDMSU128 and for E. coli MDMSU52 was 8.3.10(-5) and 4.9.10(-5) M, respectively. CONCLUSION: DL is the first invertebrate lysozyme with combined enzymatic and non-enzymatic antibacterial action.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsAnti-Infective AgentsBacteriaEndopeptidasesGlycoside HydrolasesHirudo medicinalisMicrobial Sensitivity TestsPeptide Fragments

Resumen

Heat-treated destabilase retains antibacterial activity (MIC 9.8-12x10^-8 M) against M. luteus and E. coli even with glycosidase function abolished.

Por qué esto importa para la hirudoterapia

This study investigated the antibacterial properties of destabilase-lysozyme (DL) from the medicinal leech (Hirudo medicinalis), specifically examining its non-enzymatic, non-glycosidase antibacterial action. It is highly relevant to the leech secretome, demonstrating that heat-treated DL and synthetic peptides derived from its structure retain potent antibacterial activity against pathogens like Micrococcus luteus and Escherichia coli. This reveals that leech-derived molecules possess a dual enzymatic and non-enzymatic defense mechanism. However, the scope is limited to in vitro microbial sensitivity testing of isolated or synthetic leech peptides, providing no data on the efficacy of these compounds in live animal models or clinical hirudotherapy.

Citación

Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides.

Zavalova LL et al. · Chemotherapy, 2006

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.